AXGN Q3 2019 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$29M+26.1% YoY

Gross Profit

$24M84.2% margin

Operating Income

-$6M-21.4% margin

Net Income

-$6M-19.5% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+7.0%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$154M

Total Liabilities

$19M

Stockholders' Equity

$135M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$23M	+26.1%
Gross Profit	$24M	$19M	+25.3%
Operating Income	-$6M	-$5M	-26.4%
Net Income	-$6M	-$4M	-35.8%